-transparent.png){kind=logo}
OBJECTIVE Interleukin-1 beta is a proinflammatory cytokine produced by blood-borne and resident brain inflammatory cells. The present study was conducted to determine if interleukin-1 beta mRNA was produced in the brain of rats subjected to permanent focal ischemia. METHODS Rat interleukin-1 beta cDNA, synthesized from stimulated rat peritoneal macrophage RNA by reverse transcription and polymerase chain reaction and cloned in plasmid Bluescript KS+, was used to evaluate the expression of interleukin-1 beta mRNA in cerebral cortex from spontaneously hypertensive rats and normotensive rats subjected to permanent middle cerebral artery occlusion. Interleukin-1 beta mRNA was quantified by Northern blot analysis and compared with rat macrophage RNA standard. To correct for gel loading, blots were also analyzed with cyclophilin cDNA, which encodes an abundant, conserved protein that was unchanged by the experimental conditions. RESULTS Interleukin-1 beta mRNA produced in the ischemic zone was significantly increased from 6 hours to 120 hours, with a maximum of 211 +/- 24% of interleukin-1 beta reference standard, ie, 0.2 ng stimulated rat macrophage RNA, mRNA compared with the level in nonischemic cortices (4 +/- 2%) at 12 hours after ischemia (P < .01; n = 6). Interleukin-1 beta mRNA at 12 hours after ischemia was markedly elevated in hypertensive rats over levels found in two normotensive rat strains. Neurological deficits were also apparent only in the hypertensive rats. CONCLUSIONS Brain interleukin-1 beta mRNA is elevated acutely after permanent focal ischemia and especially in hypertensive rats. These data suggest that this potent proinflammatory and procoagulant cytokine might have a role in brain damage following ischemia.
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
July 1991,
Neuroscience letters,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
September 1995,
Stroke,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
January 1992,
Glia,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
May 1997,
Journal of neuroimmunology,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
May 1995,
Brain research. Molecular brain research,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
January 1991,
Brain research. Molecular brain research,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
March 1995,
Journal of endodontics,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
January 1993,
Acta neuropathologica,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
January 2003,
Acupuncture & electro-therapeutics research,
T Liu, and
P C McDonnell, and
P R Young, and
R F White, and
A L Siren, and
J M Hallenbeck, and
F C Barone, and
G Z Feurestein
June 2001,
Neurotoxicology,
